Trial Profile
Clinical Trials Insight: 700009307
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 28 Nov 2005
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary) ; Simvastatin (Primary)
- Indications Coronary disorders; Hypercholesterolaemia
- Focus Therapeutic Use
- Sponsors Schering-Plough
- 28 Nov 2005 New trial record.